Zhang D, Liu G, Ye J, Li K, et al. Low-exhaustion peripheral circulating gammadelta T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study. BMC Cancer 2025;25:178.
PMID: 39885493